A study of glioma cells showed that knockdown of SLC7A11 increased ROS production and decreased glutathione production, resulting in increased cell death under oxidative and genotoxic stress, and overexpression of SLC7A11 leads to increased resistance to oxidative stress (Polewski et al., 2016). This evidence concerns the gene SLC7A11 and central nervous system cancer.